Literature DB >> 8250969

Stimulation of calcium release by caffeine analogs in pheochromocytoma cells.

C E Müller1, J W Daly.   

Abstract

Caffeine (EC50 approximately 20 mM) causes a maximal 400% increase in intracellular calcium ion concentration ([Ca2+]i) in pheochromocytoma PC12 cells. A range of caffeine analogs in which methyl groups at the 1, 3, and 7 positions were replaced with relatively nonpolar (ethyl, allyl, propyl, propargyl) or polar (CH2COOH, CH2CH2OH, CH2CN, CH2OCH3) substituents were tested at a 10 mM concentration. Many analogs were as efficacious or only somewhat less efficacious than 10 mM caffeine. Certain analogs with polar substituents had no effect. Disubstituted xanthines were less efficacious (theophylline, paraxanthine) than caffeine or were ineffective (theobromine). 1-Propyl-3,7-dimethylxanthine (EC50 4 mM) and 1-propargyl-3,7-dimethylxanthine (EC50 5 mM) were several-fold more potent than caffeine in causing elevation of [Ca2+]i and the latter was at least as efficacious.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250969     DOI: 10.1016/0006-2952(93)90589-o

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

2.  Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs.

Authors:  X Jiang; L Y Lim; J W Daly; A H Li; K A Jacobson; M Roberge
Journal:  Int J Oncol       Date:  2000-05       Impact factor: 5.650

3.  Stress, caffeine and ethanol trigger transient neurological dysfunction through shared mechanisms in a mouse calcium channelopathy.

Authors:  Robert S Raike; Catherine Weisz; Freek E Hoebeek; Matthew C Terzi; Chris I De Zeeuw; Arn M van den Maagdenberg; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2012-09-23       Impact factor: 5.996

4.  Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors.

Authors:  Dan Shi; William L Padgett; John W Daly
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

5.  Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).

Authors:  Catriona M H Anderson; David T Thwaites
Journal:  Biochim Biophys Acta       Date:  2007-04-14

Review 6.  Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.

Authors:  Giovanni Schepici; Serena Silvestro; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.